5007102025-10-012025-12-315007102025-12-315007102025-04-012025-12-315007102025-10-012025-12-31in-capmkt:OtherExpenses1Member5007102025-04-012025-12-31in-capmkt:OtherExpenses1Member5007102025-10-012025-12-31in-capmkt:ReportableSegments1Member5007102025-04-012025-12-31in-capmkt:ReportableSegments1Member5007102025-10-012025-12-31in-capmkt:ReportableSegments1Member5007102025-04-012025-12-31in-capmkt:ReportableSegments1Member5007102025-10-012025-12-31in-capmkt:ReportableSegments1Member5007102025-12-31in-capmkt:ReportableSegments1Member5007102025-10-012025-12-31in-capmkt:ReportableSegments1Member5007102025-12-31in-capmkt:ReportableSegments1Member5007102025-10-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15007102025-04-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss1iso4217:INRiso4217:INRxbrli:shares500710AKZOINDIANOTLISTEDINE133A01011Akzo Nobel India LimitedMain BoardEquity2025-04-012026-03-312026-02-022026-01-09INRMillionsQuarterlyThird quarterGeographical2026-02-0216:30:002026-02-0219:30:00Not applicable2025-10-012025-12-31UnauditedConsolidated90772000001466400009223840000437745000047758000039508000067409000028470000185760000178983000079282600001295580000-28264000010129400001826900008719000026988000007430600000000743060000-529600006901000004554000001016.3216.320016.3216.32Notes to the Consolidated Unaudited Financial Results for the quarter and nine months ended 31 December 2025 <BR> <BR> 1. The Consolidated Unaudited Financial Results have been reviewed by the Audit Committee and approved by the Board of Directors in their meeting held on 02 February 2026. The figures for the quarter and nine months ended 31 December 2025 have been subjected to limited review by the statutory auditors. <BR> <BR> 2. The Consolidated Unaudited Financial Results include the results of the following entities namely, Akzo Nobel India Limited (Holding Company) and ICI India Research and Technology Centre Private Limited (Formerly known as ICI India Research and Technology Centre) (Subsidiary), hereinafter referred to as the Group. <BR> <BR> 3. The Group is principally engaged in the business of manufacturing paints, coatings and allied products in India with similar risk, returns and internal business reporting system. Accordingly, there are no reportable segment(s) other than "Paints", which singly or in aggregate qualify for separate disclosure as per provisions of the relevant Ind AS 108 "Operating segments”. <BR> <BR> 4. During the quarter and nine months ended 31 December 2025, the Group recognised exceptional items amounting to INR 283 million and INR 18,459 million respectively. The details of the same are as follows: <BR> <BR> Particulars Quarter ended <BR> 31 December 2025 Nine months ended <BR> 31 December 2025 <BR> Profit from the slump sale of the Powder Coatings business division and the International Research Center division (net of directly attributable expenses) - 18,925 <BR> Provision on account of impairment of property, plant and equipment rendered unusable pursuant to the above slump sale (at net book value) - (79) <BR> Reimbursement towards additional costs incurred pursuant to the above slump sale 71 71 <BR> Impact of new Labour Codes* (317) (317) <BR> Retention incentive (37) (141) <BR> Total – (Expense) / Income (283) 18,459 <BR> <BR> * The Government of India has notified the Code on Social Security, 2020; the Occupational Safety, Health and Working Conditions Code, 2020; the Industrial Relations Code, 2020 and the Code on Wages, 2019 (collectively, the "Labour Codes") on November 21, 2025. The Ministry of Labour & Employment published draft Central Rules and FAQs to enable assessment of the financial impact due to Labour Codes. The Group has evaluated the impact of increased employee benefits obligations arising from the implementation of the Labour Codes based on its best judgment in consultation with external experts. Accordingly, the Group has recognised a financial impact of Rs. 317 million in accordance with Ind AS 19 - 'Employee Benefits' and disclosed it as an Exceptional Item in the financial results for the quarter and nine months ended 31 December 2025. <BR> The Group will continue to monitor the finalization of Central and State Rules and further Government clarifications, and will record any additional accounting impact, as required. <BR> <BR> 5. Current tax for the nine months ended 31 December 2025 includes an amount of INR 2,704 million in respect of slump sale of Powder Coatings business division and the International Research Center division during the previous quarter. Also, deferred tax for the nine months ended 31 December 2025 includes an amount of INR 544 million (charge) in respect of taxable timing differences related to IPRs capitalised during the previous quarter. <BR> <BR> 6. During the quarter, the Group completed the sale of its lease hold immovable property at Nerul (Mumbai, Maharashtra) resulting in a gain of Rs. 111 million which has been recognized as Other income in the Consolidated Unaudited Financial Results for the quarter and nine months ended 31 December 2025. <BR> <BR> 7. On 10 December 2025, JSW Paints Limited (JSW) acquired 60.76% shares of the Holding Company under Share Purchase Agreement entered with Imperial Chemical Industries Limited and Akzo Nobel Coatings International B.V. Pursuant to the acquisition, JSW holds 61.2% of the paid-up equity share capital of the Holding Company and is now classified as the promoter of the Holding Company. Imperial Chemical Industries Limited, Akzo Nobel Coatings International B.V. and Akzo Nobel N.V. have ceased to be part of the promoter / promoter group of the Holding Company with effect from 10 December 2025. <BR> <BR> 8. The Consolidated Unaudited Financial Results for the quarter and nine months ended 31 December 2025 are not comparable with the corresponding previous periods due to the slump sale of the Powder Coatings business division and the International Research Center division during the quarter ended 30 September 2025. <BR> <BR> <BR> <BR> <BR> Mumbai Rajiv Rajgopal <BR> <BR> 02 February 2026 Jt. Managing Director & CEO <BR> <BR> 2025-04-012025-12-31UnauditedConsolidated27377320000313720000276910400001397040000014365500004327200002380250000781700005517500005342450000241922900003498750000184593400002195809000030845900003922000003476790000018481300000000018481300000-680500001841325000045540000010405.82405.8200405.82405.82Other Expenses1789830000Other Expenses5342450000Paints9077200000Paints2737732000090772000002737732000000907720000027377320000Paints1041610000Paints220362700001041610000220362700002847000078170000101314000021958100000Paints3810400000038104000000038104000000Paints3810400000038104000000038104000000Gain/(Loss) of defined benefit plans-70950000-70950000Gain/(Loss) of defined benefit plans-91000000-91000000-17990000-22950000-52960000-68050000